z-logo
open-access-imgOpen Access
p53 Targets Simian Virus 40 Large T Antigen for Acetylation by CBP
Author(s) -
Danielle L. Poulin,
Andrew L. Kung,
James A. DeCaprio
Publication year - 2004
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.78.15.8245-8253.2004
Subject(s) - acetylation , biology , sv40 large t antigen , p300 cbp transcription factors , antigen , carcinogenesis , suppressor , microbiology and biotechnology , binding site , plasma protein binding , cell culture , biochemistry , genetics , transfection , gene , histone acetyltransferases
Simian virus 40 (SV40) large T antigen (T Ag) interacts with the tumor suppressor p53 and the transcriptional coactivators CBP and p300. Binding of these cellular proteins in a ternary complex has been implicated in T Ag-mediated transformation. It has been suggested that the ability of CBP/p300 to modulate p53 function underlies p53's regulation of cell proliferation and tumorigenesis. In this study, we provide further evidence that CBP activity may be mediated through its synergistic action with p53. We demonstrate that SV40 T Ag is acetylated in vivo in a p53-dependent manner and T Ag acetylation is largely mediated by CBP. The acetylation of T Ag is dependent on its interaction with p53 and on p53's interaction with CBP. We have mapped the site of acetylation on T Ag to the C-terminal lysine residue 697. This acetylation site is conserved between the T antigens of the human polyomaviruses JC and BK, which are also known to interact with p53. We show that both JC and BK T antigens are also acetylated at corresponding sites in vivo. While other proteins are known to be acetylated by CBP/p300, none are known to depend on p53 for acetylation. T Ag acetylation may provide a regulatory mechanism for T Ag binding to a cellular factor or play a role in another aspect of T Ag function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here